$439 Million is the total value of PAX Financial Group, LLC's 215 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HBAN | Exit | HUNTINGTON BANCSHARES INC | $0 | – | -15,000 | -100.0% | -0.04% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -1,861 | -100.0% | -0.05% | – |
| PLD | Exit | PROLOGIS INC. | $0 | – | -1,688 | -100.0% | -0.05% | – |
| VNQ | Exit | VANGUARD INDEX FDSreal estate etf | $0 | – | -2,587 | -100.0% | -0.05% | – |
| BAC | Exit | BANK AMERICA CORP | $0 | – | -15,586 | -100.0% | -0.10% | – |
| CTSH | Exit | COGNIZANT TECHNOLOGY SOLUTIOcl a | $0 | – | -7,113 | -100.0% | -0.10% | – |
| SHY | Exit | ISHARES TR1 3 yr treas bd | $0 | – | -6,397 | -100.0% | -0.12% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -2,296 | -100.0% | -0.12% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -52,429 | -100.0% | -0.12% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -4,818 | -100.0% | -0.12% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -3,427 | -100.0% | -0.13% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -27,458 | -100.0% | -0.13% | – |
| CAG | Exit | CONAGRA BRANDS INC | $0 | – | -17,138 | -100.0% | -0.13% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -2,222 | -100.0% | -0.13% | – |
| FSK | Exit | FS KKR CAP CORP | $0 | – | -31,196 | -100.0% | -0.14% | – |
| TTEC | Exit | TTEC HLDGS INC | $0 | – | -17,637 | -100.0% | -0.14% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -30,507 | -100.0% | -0.14% | – |
| CENT | Exit | CENTRAL GARDEN & PET CO | $0 | – | -15,870 | -100.0% | -0.14% | – |
| ENR | Exit | ENERGIZER HLDGS INC NEW | $0 | – | -18,882 | -100.0% | -0.14% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -14,131 | -100.0% | -0.15% | – |
| CHEF | Exit | CHEFS WHSE INC | $0 | – | -19,107 | -100.0% | -0.15% | – |
| SFM | Exit | SPROUTS FMRS MKT INC | $0 | – | -18,798 | -100.0% | -0.16% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -65,526 | -100.0% | -0.19% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -9,591 | -100.0% | -0.20% | – |
| FALN | Exit | ISHARES TRfaln angls usd | $0 | – | -38,736 | -100.0% | -0.22% | – |
| TLH | Exit | ISHARES TR10-20 yr trs etf | $0 | – | -26,594 | -100.0% | -0.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 16 | Q3 2023 | 16.2% |
| ISHARES TR | 16 | Q3 2023 | 10.7% |
| ISHARES TR | 16 | Q3 2023 | 8.6% |
| SPDR SER TR | 16 | Q3 2023 | 4.5% |
| SPDR SER TR | 16 | Q3 2023 | 3.2% |
| SPDR INDEX SHS FDS | 16 | Q3 2023 | 2.0% |
| SPDR SER TR | 16 | Q3 2023 | 2.0% |
| SPDR SER TR | 16 | Q3 2023 | 1.9% |
| VANGUARD INDEX FDS | 16 | Q3 2023 | 1.7% |
| ISHARES TR | 16 | Q3 2023 | 2.2% |
View PAX Financial Group, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-18 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-07 |
| 13F-HR | 2021-10-29 |
View PAX Financial Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.